A higher intradaily variability predicted an increased cognitive decline at one year of follow-up (effect size [95% CI] of -0.715 [-1.272 to -0.157]) after adjusting for age, sex, T-tau/Aβ42 ratio, educational level, and season of the year (Fig. 2). The gene discussed is MAPT; the disease is Mental deterioration.